跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
SOLIFENACIN GH solifenacin succinate 5mg tablet blister pack
Approved
STANDARD
SOLIFENACIN GH solifenacin succinate 5mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
1c7cb37d1aae38c3
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
1c7cb37d1aae38c3
Product Name
SOLIFENACIN GH solifenacin succinate 5mg tablet blister pack
Artg Id
248406
Artg Name
SOLIFENACIN GH solifenacin succinate 5mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2016-05-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
1c7cb37d1aae38c3
Type
Standard
Back to TGA Approvals
SOLIFENACIN GH solifenacin succinate 5mg tablet blister pack - TGA Drug Approval Details
